We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

REGCO:NASDAQRegency Centers Corporation - 5.875% Series B Cumulative Redeemable Preferred Stock Analysis

Data as of 2026-05-23 - not real-time

$22.39

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Regency Centers trades at $22.39, just above its 20‑day (22.32) and 50‑day (22.16) SMAs but still below the 200‑day SMA (22.69), indicating a short‑term bullish tilt within a neutral longer‑term backdrop. The MACD line sits marginally above its signal (0.088 vs 0.075) and the histogram is positive, while the RSI at 51 confirms the market is neither overbought nor oversold. Volume is increasing, and the price is comfortably above the identified support of $21.63, giving the stock room to test the $22.82 resistance.
Fundamentally, REGCO offers an attractive 6.56% dividend yield backed by solid operating cash flow ($819 M) and free cash flow ($575 M), yet earnings per share are currently zero and debt sits at $5.25 B with a debt‑to‑equity of 73, raising questions about dividend sustainability. The price‑to‑book of 0.61 suggests the market values the company well below its book value, pointing to a potential undervaluation, while the low beta (0.27) implies limited price volatility relative to the market.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Bullish MACD crossover and price above short‑term SMAs
  • Increasing volume supporting upward momentum
  • High dividend yield offering immediate income

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Elevated debt load relative to equity
  • Zero EPS raising concerns on earnings sustainability
  • Stable cash flow but potential pressure from retail sector trends

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Undervalued price‑to‑book ratio indicating margin of safety
  • Uncertain dividend sustainability without earnings
  • Low market beta and moderate volatility supporting defensive profile

Key Metrics & Analysis

Financial Health

Revenue Growth10.00%
Profit Margin33.11%
ROE8.00%
ROA3.21%
Debt/Equity73.22
P/B Ratio0.6
Op. Cash Flow$819.4M
Free Cash Flow$574.6M
Industry P/E32.7

Technical Analysis

TrendNeutral
RSI51.4
Support$21.63
Resistance$22.82
MA 20$22.32
MA 50$22.16
MA 200$22.69
MACDBullish
VolumeIncreasing
Fear & Greed Index91.61

Valuation

GradeUndervalued
TypeValue
Dividend Yield6.56%

Risk Assessment

Beta0.27
Volatility14.68%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.